SCHEDULE: FMR LLC Reports 12.4% Stake in Biogen Inc.
Ownership Filing Amendment
FMR LLC and Abigail P. Johnson have updated their Schedule 13G filing, reporting a combined beneficial ownership of 12.4% of Biogen Inc.'s common stock as of June 30, 2026.
Summary
- FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, indicating their beneficial ownership of Biogen Inc. common stock.
- As of June 30, 2026, the total beneficial ownership reported is 18,294,523.51 shares, representing 12.4% of the class.
- FMR LLC holds sole voting power for 16,623,432.57 shares and sole dispositive power for 18,294,523.51 shares.
- Abigail P. Johnson is identified as a key individual associated with FMR LLC's reporting, holding significant dispositive power.
- The filing confirms that no single other person's interest in Biogen Inc. exceeds five percent of the total outstanding common stock.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily reflecting routine ownership updates rather than significant strategic shifts or performance indicators.
Positives
- FMR LLC and Abigail P. Johnson maintain a significant stake in Biogen Inc., indicating continued investor confidence.
- The reporting entities have clear sole voting and dispositive power over a substantial number of shares, suggesting strong control over their holdings.
Negatives
- The filing is an amendment to a Schedule 13G, which typically indicates routine updates rather than new positive developments.
Risks
- The filing does not explicitly mention any new risks or challenges faced by Biogen Inc. or the reporting entities.
Future Outlook
The filing does not contain forward-looking statements or specific guidance regarding Biogen Inc.'s future performance.
Management Comments
- FMR LLC and Abigail P. Johnson certify that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
StockSavvy.ai notes that this filing is a standard Schedule 13G amendment, common for large institutional investors like FMR LLC. It reflects ongoing investment positions rather than new strategic initiatives or performance evaluations for Biogen Inc. within the biotechnology sector.
Stakeholder Impact
- Shareholders: The filing confirms a significant institutional investor's stake, which can influence market perception and trading activity.
Next Steps
- FMR LLC and Abigail P. Johnson will continue to hold and manage their beneficial ownership of Biogen Inc. common stock.
Key Dates
| Date | Description |
|---|---|
| 01/03/2023 | Effective date of Power of Attorney for FMR LLC. |
| 01/10/2023 | Filing date of Schedule 13G by FMR LLC (referenced for Power of Attorney incorporation). |
| 01/26/2023 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 01/31/2023 | Filing date of Schedule 13G by FMR LLC (referenced for Power of Attorney incorporation). |
| 06/30/2026 | Date of Event Which Requires Filing of this Statement (Reporting period end date). |
| 08/05/2026 | Date of joint filing and execution of Rule 13d-1(k)(1) agreement. |
Keywords
Biogen Inc., FMR LLC, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.